Explosion at Williams in Geismar Claims Two Lives

An explosion and fire in a cracker on June 13 at the Williams olefins plant in Tulsa, Oklahoma, U.S., has claimed two lives, according to local authorities. The first death, immediately following the blast believed to have resulted from the ignition of propylene and propane, was a plant operator. The second, the plant's operations supervisor, succumbed to severe burns a day later. Some 70 employees were reported injured.

On June 17, Williams was still investigating the cause of the accident, which is said to have occurred during routine maintenance. The cracker remains offline, and a date for a restart has not been announced. U.S. government agencies, including the Environmental Protection Agency (EPA) and the Louisiana Department of Environmental Quality (LDEQ) have announced participation in the investigation. U.S. spot ethylene prices spiked temporarily on the news.

Companies with downstream facilities at the Geismar site include BASF, which produces ethylene oxide, Shell Chemicals, and PVC producer Westlake. All plants were believed to be operating normally following the incident. According to press reports, a worker at the BASF plant, who said he suffered throat burns and breathing problems as a result of the blast, has filed a lawsuit against Williams, charging negligence. He also is said to be seeking class action status for the complaint.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.